Research ArticleArticle
Molecular Mechanisms Underlying the Synergistic Interaction of Erlotinib, an Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor, with the Multitargeted Antifolate Pemetrexed in Non-Small-Cell Lung Cancer Cells
Elisa Giovannetti, Clara Lemos, Christina Tekle, Kees Smid, Sara Nannizzi, José A. Rodriguez, Simona Ricciardi, Romano Danesi, Giuseppe Giaccone and Godefridus J. Peters
Molecular Pharmacology April 2008, 73 (4) 1290-1300; DOI: https://doi.org/10.1124/mol.107.042382
Elisa Giovannetti
Clara Lemos
Christina Tekle
Kees Smid
Sara Nannizzi
José A. Rodriguez
Simona Ricciardi
Romano Danesi
Giuseppe Giaccone
Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
Research ArticleArticle
Molecular Mechanisms Underlying the Synergistic Interaction of Erlotinib, an Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor, with the Multitargeted Antifolate Pemetrexed in Non-Small-Cell Lung Cancer Cells
Elisa Giovannetti, Clara Lemos, Christina Tekle, Kees Smid, Sara Nannizzi, José A. Rodriguez, Simona Ricciardi, Romano Danesi, Giuseppe Giaccone and Godefridus J. Peters
Molecular Pharmacology April 1, 2008, 73 (4) 1290-1300; DOI: https://doi.org/10.1124/mol.107.042382
Research ArticleArticle
Molecular Mechanisms Underlying the Synergistic Interaction of Erlotinib, an Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor, with the Multitargeted Antifolate Pemetrexed in Non-Small-Cell Lung Cancer Cells
Elisa Giovannetti, Clara Lemos, Christina Tekle, Kees Smid, Sara Nannizzi, José A. Rodriguez, Simona Ricciardi, Romano Danesi, Giuseppe Giaccone and Godefridus J. Peters
Molecular Pharmacology April 1, 2008, 73 (4) 1290-1300; DOI: https://doi.org/10.1124/mol.107.042382
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement